Synthesis of (-)-epigallocatechin-3-gallate derivative containing a triazole ring and combined with cisplatin/paclitaxel inhibits NSCLC cancer cells by decreasing phosphorylation of the EGFR

Hydroxyl Alkyl Ammonium Ionic liquid assisted Green and One-pot regioselective access to Functionalized Pyrazolodihydropyridine core and their pharmacological evaluation

(2019) Divyang M. Patel et al.   BIOORGANIC CHEMISTRY

Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art

(2018) Weronika Maria Szejniuk et al.   PHARMACOGENOMICS JOURNAL

Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives

(2016) Xin Zhang et al.   MOLECULES

Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer

(2015) Lecia V. Sequist et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?

(2014) Álvaro Henrique Ingles Garces et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q

(2014) Satoshi Watanabe et al.   Journal of Thoracic Oncology

AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

(2014) D. A. E. Cross et al.   Cancer Discovery

Click Chemistry for Drug Development and Diverse Chemical–Biology Applications

(2013) Prakasam Thirumurugan et al.   CHEMICAL REVIEWS

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

(2013) Marina Chiara Garassino et al.   LANCET ONCOLOGY

Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway

(2013) YU-CHAO MA et al.   ONCOLOGY REPORTS

Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells

(2013) LONGYU JIN et al.   ONCOLOGY REPORTS

Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane

(2013) Huaping Chen et al.   Journal of Oncology

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

(2008) Jean-Pierre Pignon et al.   JOURNAL OF CLINICAL ONCOLOGY